本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Artelo Biosciences, Inc.

5.43
-0.2000-3.55%
盤後5.30-0.1300-2.39%19:47 EDT
成交量:4.16萬
成交額:23.62萬
市值:297.44萬
市盈率:-0.05
高:5.84
開:5.69
低:5.35
收:5.63
52周最高:179.19
52周最低:4.68
股本:54.78萬
流通股本:54.74萬
量比:1.51
換手率:7.60%
股息:- -
股息率:- -
每股收益(TTM):-102.4151
每股收益(LYR):-337.9329
淨資產收益率:-705.71%
總資產收益率:-127.92%
市淨率:0.60
市盈率(LYR):-0.02

資料載入中...

2025/04/29

重要事件披露

Form 8-K - Current report
2025/03/20

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/03

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/12/20

重要事件披露

Form 8-K - Current report
2024/11/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/06/17

交易所摘牌聲明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2024/05/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/03/29

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/25

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/04

重要事件披露

Form 8-K - Current report
2023/11/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/08

重要事件披露

Form 8-K - Current report
2023/07/12

SEC問詢函

Form CORRESP - Correspondence
2023/07/04

重要事件披露

Form 8-K - Current report
2023/05/11

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/04/21

重要事件披露

8-K - Current report
2023/04/21

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/31

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]